Hansol Lee1, Sun-Yong Baek2, Eun-Joo Kim3, Gi Yeong Huh4, Jae-Hyeok Lee5, and HyungJoon Cho1
1Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Korea, Republic of, 2Department of Anatomy, Pusan National University School of Medicine, Yangsan, Korea, Republic of, 3Department of Neurology, Pusan National University Hospital, Busan, Korea, Republic of, 4Department of Forensic Medicine, Pusan National University School of Medicine, Yangsan, Korea, Republic of, 5Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea, Republic of
Synopsis
The purpose of this study was to determine the alteration of the
morphology in the substantia nigra using MRI with histopathological validation
for the patients of atypical Parkinsonism. MR experiments for formalin fixed
autopsied brains were operated using a 7T imaging system. Specific
visualization of ferric iron and neuromelanin from MR relaxometry was used to
identify the neuromelanin distribution within the normal brain and the brain of
Perry syndrome. The loss of neuromelanin pigment within the substantia nigra of
Perry syndrome was consistently confirmed both from MR relaxometry and from the
directly captured picture during the cryo-section.
Purpose
Neuromelanin is a dark-brown pigmented granule which stores iron
molecules in dopaminergic neurons of substantia nigra (SN).1 The
significant loss of neuromelanin pigment was identified in the SN of
Parkinsonism.1 Perry syndrome (PS) is a kind of rarely hereditary neurodegenerative disease.2 It is characterized by the
neuronal destruction with distinct TDP-43 pathology.2 Noninvasively distinguishing the distribution and the density of neuromelanin
pigment of normal brain and the brain of Parkinsonism is meaningful to investigate
the progression of PS. The T1 weighted image with magnetization
transfer (MT) effects has been reported to suggest the distribution of
neuromelanin by neuromelanin specific hyperintense contrast.3 In
addition, the effective size difference between iron molecules and
neuromelanin-iron complex influences differently to T2 and T2* values.4
The aim of this study was to determine the change of iron deposits and
iron-chelated neuromelanin within postmortem SN of PS patients by combining
quantitative MR relaxometries on verifiable postmortem normal and PS brain.Method
The
midbrain samples were obtained during the autopsies of the normal brain without
any evidence of neurodegenerative disorders and the brain of PS from Pusan National University Brain Bank and Pusan
National University Anatomical Donation Program. Experiments of this postmortem study were
conducted under the approval of institutional review board of Pusan National
University Yangsan Hospital and Ulsan National Institute of Science and
Technology. The tissues were fixed in 10% formalin and processed accordingly.
Postmortem MR experiments at 7T preclinical scanner (Bruker, Germany) were
performed for neuromelanin-sensitive T1 weighted image with MT
effects, Quantitative susceptibility mapping (QSM) from calculation of susceptibility through multiple orientation sampling (COSMOS), T2 map, T2*
map, and T2*/T2 map. For the direct pathological validation,
histochemical examinations were implemented for both cases. The cryoprotected
tissues by sucrose solution were sectioned to the slice of 50 μm thickness.Result
The MR
images were shown for the brain of healthy control and PS in Figure 1 and
Figure 2 including T1 weighted image with MT effects (A), MT ratio (B), QSM
from COSMOS (C), T2 map (D), T2* map (E), T2*/T2 map (F). For the healthy control, T1
weighted image with MT effects (Figure 1A) showed hyperintense area on the whole
SN. The MT ratio (Figure 1B) processed from the T1 weighted image without MT
effect and with MT effect presented the high values on the myelin fiber of
white matter. The QSM from COSMOS (Figure 1C) showed paramagnetic lines within
the SN which suggest the distribution of paramagnetic neuromelanin-iron complex
in SN detected from sectioned slide (Figure 3C). Both neuromelanin-iron complex
and iron deposition contributed to shortening T2* (Figure 1E). T2
map (Figure 1D) presented the distribution of ferric iron near the boundary between
SN and cerebral peduncle (CP). The effect of iron deposition on shortened T2*
map was accordingly reduced in T2*/T2 map (Figure 1F) only producing
the contrast for the distribution of iron-chelated neuromelanin. For the case
of PS, the projected myelin tracts to the SN were shown as hypointense line
(black arrow) in T1 weighted image with MT effects (Figure 2A) and high values
in MT ratio (Figure 2B). QSM (Figure 2C) showed paramagnetic regions
for the myelin tract and along the boundary between SN and
CP. The paramagnetic myelin tract appears in the T2* map (Figure 2E) with broad
iron deposition with shortened values. The shortened regions of T2 map (Figure
2D) were only correlated to the iron deposition. T2*/T2 map showed
significantly developed contrast for projected myelin fiber with reduced effect
of iron deposition. No significant neuromelanin distribution was observed in T2*/T2 map (Figure 3B) and cryo-sections (Figure 3D).Discussion
In our
study, the evidence of neuromelanin pigment was shown in T2*/T2 map of normal
brain. However, it cannot be found in the brain of PS which was
validated from the cryo-sectioned slide. The myelin tracts
projected to SN were only shown as the noticeable contrast in T2*/T2 map from
their paramagnetic characteristics with shortened T2*. The myelin fibers of
PS were predicted to transport iron molecules between two
compartments of the brain tissues as the pallidal-nigral pathways, fascicula
nigrale.5 Due to the destruction of the iron transport mechanism,
the high concentration of iron molecules were suggested to be deposited in the
myelin tract.
Commonly,
shortened T2 values were highly connected to the deposited iron molecules
regardless of the concentration of iron molecules. The T2* values were
associated with the size of the architecture such as the radius of the cylinder
and the sphere. Therefore, the neuromlenanin-iron complex from normal brain and myelin
tract of PS which contains high concentration of iron molecules can be separated in
the SN by T2*/T2 technique.
Acknowledgements
This work was supported by the Korea Health Industry Development Institute by the 2018 Research Fund (HI18C0713).References
1. Gerlach, M., Double, K. L., Ben-Shachar, D., Zecca, L., Youdim, M. B.,
& Riederer, P. (2003). Neuromelanin and its interaction with iron as a
potential risk factor for dopaminergic neurodegeneration underlying Parkinson's
disease. Neurotoxicity Research, 5(1-2), 35-43.
2. Konno, T., Ross, O. A., Teive, H. A., SÅ‚awek, J., Dickson, D. W., & Wszolek, Z. K. (2017). DCTN1-related neurodegeneration: Perry syndrome and beyond. Parkinsonism & related disorders, 41, 14-24.
3. Sasaki, M., Shibata, E., Kudo, K., & Tohyama, K. (2008).
Neuromelanin-sensitive MRI. Clinical Neuroradiology, 18(3),
147-153.
4. Lee, H., Baek, S. Y., Chun, S. Y., Lee, J. H., & Cho, H. (2018).
Specific visualization of neuromelanin-iron complex and ferric iron in the
human post-mortem substantia nigra using MR relaxometry at 7T. Neuroimage, 172,
874-885.
5. Peckham, M. E., Dashtipour, K., Holshouser, B. A., Kani, C., Boscanin,
A., Kani, K., & Harder, S. L. (2016). Novel pattern of iron deposition in
the fascicula nigrale in patients with Parkinson’s disease: a pilot
study. Radiology research and practice, 2016.